Last 4,470 GBp
Change Today -63.00 / -1.39%
Volume 295.9K
SHP On Other Exchanges
Symbol
Exchange
SHP is not on other exchanges.
As of 7:35 AM 12/24/14 All times are local (Market data is delayed by at least 15 minutes).

Audit Committee* - shire plc (SHP)

Name (Connections)Board RelationshipsTitleKey Developments
Susan Saltzbart Kilsby 46 RelationshipsNon-Executive Chairman, Member of Audit, Compliance & Risk Committee and Member of Nomination CommitteeShire Pharmaceuticals Group plc Restates its Financial Results for the Year 2003
08/3/04
David Kappler 40 RelationshipsDeputy Chairman, Senior Independent Non-executive Director, Chairman of Nomination Committee and Member of Audit, Compliance & Risk Committee 
Dominic Blakemore 18 RelationshipsNon-Executive Director and Chairman of Audit, Compliance & Risk Committee 
David Stout 47 RelationshipsIndependent Non-Executive Director, Member of Audit, Compliance & Risk Committee and Member of Remuneration Committee 

Compensation Committee* - shire plc (SHP)

Name (Connections)Board RelationshipsTitle
William Burns BA 63 RelationshipsIndependent Non-Executive Director, Member of Nomination Committee, Member of Remuneration Committee and Member of Science & Technology Committee
Steven Gillis M.D., Ph.D. 159 RelationshipsIndependent Non-Executive Director, Member of Remuneration Committee and Member of Science & Technology Committee
Anne Minto OBE 28 RelationshipsIndependent Non-Executive Director, Chairman of Remuneration Committee and Member of Nomination Committee
David Stout 47 RelationshipsIndependent Non-Executive Director, Member of Audit, Compliance & Risk Committee and Member of Remuneration Committee
SHP Compensation vs. Industry
1.1M
415.1K
Chief Executive Officer
Share price activity for SHIRE PLC (SHP)
52 Week Price Performance
SHP
Industry Average

Nominating Committee* - shire plc (SHP)

Name (Connections)Board RelationshipsTitleKey Developments
Susan Saltzbart Kilsby 46 RelationshipsNon-Executive Chairman, Member of Audit, Compliance & Risk Committee and Member of Nomination CommitteeShire plc Announces Board Changes
01/23/14
David Kappler 40 RelationshipsDeputy Chairman, Senior Independent Non-executive Director, Chairman of Nomination Committee and Member of Audit, Compliance & Risk CommitteeShire plc Appoints Dominic Blakemore as Non-Executive Director and Member, Effect from January 1, 2014
10/23/13
Anne Minto OBE 28 RelationshipsIndependent Non-Executive Director, Chairman of Remuneration Committee and Member of Nomination CommitteeShire plc Announces Director Appointments
05/1/13
William Burns BA 63 RelationshipsIndependent Non-Executive Director, Member of Nomination Committee, Member of Remuneration Committee and Member of Science & Technology CommitteeShire plc to Appoint Mike Yasick as Interim Head of Specialty Pharma Business
02/14/13

Executive Committee* - shire plc (SHP)

Name (Connections)Board RelationshipsTitle
Michael Cola 75 RelationshipsFormer Executive Officer
Barbara Deptula 7 RelationshipsFormer Chief Corporate Development Officer, Executive Vice President and Member of Management Committee
Anita Graham 0 RelationshipsFormer Chief Administrative Officer, Executive Vice President of Corporate Business Services and Member of Management Committee
John Lee 0 RelationshipsFormer Executive Vice President of Global Supply Chain & Quality
Jeffrey Leiden M.D., Ph.D. 120 RelationshipsFormer Vice Chairman, Chairman of Science & Technology Committee, Member of Nomination Committee and Member of Remuneration Committee
David Pendergast Ph.D. 2 RelationshipsFormer Executive Vice President of human genetic therapies
Joseph Rus 8 RelationshipsFormer Executive Vice President of Market Alliance & New Product Development and Member of Management Committee
Eliseo Salinas M.D., M.Sc. 0 RelationshipsFormer Chief Scientific Officer, Executive Vice President of Global Research & Development and Member of Management Committee
Management Effectiveness Relative to the Industry
Return on Equity
1.2x
Return on Assets
1.6x
Return on Total Capital
1.8x
TEV/Total Revenue(LTM)
1.8x
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SHP:LN 4,470.00 GBp -63.00

SHP Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Allergan Inc/United States $210.12 USD +0.95
Astellas Pharma Inc ¥1,713 JPY +3.00
CSL Ltd A$87.47 AUD -0.19
Mylan Inc/PA $56.97 USD +0.39
Valeant Pharmaceuticals International Inc C$163.19 CAD -0.41
View Industry Companies
 

Industry Analysis

SHP

Industry Average

Valuation SHP Industry Range
Price/Earnings 22.4x
Price/Sales 7.1x
Price/Book 6.3x
Price/Cash Flow 31.6x
TEV/Sales 7.1x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SHIRE PLC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.